Maia BiotechnologyMAIA
13F holders, Q1 2025 (March 31)20holders
3new positions
3sold out
$1.53avg. 13F price*
At the end of Q1 2025, 20 institutions reported holding Maia Biotechnology Inc. (MAIA) in their 13F filings, unchanged from Q4 2024. 3 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($995K), Halter Ferguson Financial Inc. ($363K) and Geode Capital Management, LLC ($328K).
- Company
- Maia Biotechnology Inc.
- CUSIP
- 552641102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $17K |
| Exits | 3 | $84K |
All 13F filers, Q4 2024 → Q1 2025: 145,646 shares bought and 59,311 shares sold, net +86,335 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Vanguard Group Inc. | 0.00% | Add +11.6% | 650,256 | $995K |
| Halter Ferguson Financial Inc. | 0.20% | Reduce -1.4% | 237,356 | $363K |
| Geode Capital Management, LLC | 0.00% | Add +8.6% | 214,437 | $328K |
| BlackRock, Inc. | 0.00% | Reduce -0.8% | 84,083 | $129K |
| Centric Wealth Management | 0.03% | Add +0.0% | 68,248 | $104K |
| Susquehanna International Group, LLP | 0.00% | Add +373.0% | 55,100 | $84K |
| State Street Corp. | 0.00% | No change | 53,250 | $81K |
| Northern Trust Corp. | 0.00% | Add +21.7% | 39,032 | $60K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -21.2% | 36,000 | $55K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 14,800 | $23K |
| Naviter Wealth, LLC | 0.00% | New | 10,000 | $16K |
| Osaic Holdings, Inc. | 0.00% | No change | 7,450 | $11K |
| Morgan Stanley | 0.00% | No change | 5,095 | $8K |
| MAI Capital Management | 0.00% | No change | 675 | $1K |
| Bernard Wealth Management Corp. | 0.00% | No change | 500 | $765 |
| UBS Group AG | 0.00% | New | 300 | $459 |
| Jones Financial Companies LLLP | 0.00% | New | 228 | $369 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -92.7% | 239 | $366 |
| Bank of America Corp. | 0.00% | Add +9.2% | 179 | $274 |
| JPMorgan Chase & Co. | 0.00% | Reduce -6.7% | 42 | $64 |
"% of holder's portfolio" is MAIA's weight in each manager's 13F, not the share of Maia Biotechnology Inc. the manager owns.